Vancouver, British Columbia--(Newsfile Corp. - August 2, 2016) - True Leaf Medicine International Ltd. (CSE: MJ) (the
"Company"), has established a subsidiary based in Luxembourg to conduct its business in Europe.
The subsidiary, True Leaf Pet Europe LLC SARL, was incorporated effective July 18, 2016. The Company entered into a subscription
agreement to purchase 498 shares of True Leaf Pet Europe LLC SARL at a price of 25 € per share; the Company now holds 98% of the
issued and outstanding shares of True Leaf Pet Europe LLC SARL.
Darcy Bomford, President and CEO of the True Leaf Medicine International Inc., said the establishment of a European corporation
allows the Company to work in close proximity to European clients and markets. The subsidiary will work with European marketing
partner Pet Horizons to build distribution networks and develop sales and distribution performance. It will also allow True Leaf to
conduct business in European currency.
About True Leaf Medicine International Ltd:
True Leaf Medicine International Ltd. is entering the $104.9 billion global pet care industry with a line of hemp-focused pet
chews and supplements marketed through natural pet health and veterinary channels in Canada and the US. The company has also filed
an application under Health Canada's Marihuana for Medicinal Purposes Regulations (MMPR) to become a Canadian licensed producer
through its 'True Leaf Medicine' subsidiary. It has passed through the preliminary and enhanced screening process of Health
Canada's review and is currently awaiting security clearance and 'pre-licensing inspection' approval.
Media Contact:
Paul Sullivan
BreakThrough Communications
O: 604-685-4742
M: 604-603-7358
Contact:
Kevin Bottomley
Director
True Leaf Medicine International Ltd
M: +1 778 389 9933
kevin@trueleaf.com
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE
ADEQUACY OR ACCURACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION
This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect",
"may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although
the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue
reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to
be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks
and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from
those currently anticipated due to a number of factors and risks various risk factors discussed in the Company's Management's
Discussion and Analysis under the Company's profile on www.sedar.com. While the Company may
elect to, it does not undertake to update this information at any particular time.
